(Q43094166)

English

Multiple-dose pharmacokinetics and safety of the new antifungal triazole BAL4815 after intravenous infusion and oral administration of its prodrug, BAL8557, in healthy volunteers

scientific article published in January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Multiple-dose pharmacokinetics and safety of the new antifungal triazole BAL4815 after intravenous infusion and oral administration of its prodrug, BAL8557, in healthy volunteers (English)

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Anne Schmitt-Hoffmann

1

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Brigitte Roos

2

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Jürgen Maares

3

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Markus Heep

4

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Jochen Spickerman

5

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Erhard Weidekamm

6

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Tom Brown

7

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Michael Roehrle

8

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

language of work or name

0 references

publication date

1 January 2006

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

50

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

1

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

286-293

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Single-ascending-dose pharmacokinetics and safety of the novel broad-spectrum antifungal triazole BAL4815 after intravenous infusions (50, 100, and 200 milligrams) and oral administrations (100, 200, and 400 milligrams) of its prodrug, BAL8557, in h

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346776

25 May 2018

Recent developments in the management of invasive fungal infections in patients with hematological malignancies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346776

25 May 2018

Urinary 6?-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346776

25 May 2018

Current management of fungal infections.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346776

25 May 2018

An overview of fungal infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346776

25 May 2018

Pharmacokinetics and safety of a 7-day administration of intravenous itraconazole followed by a 14-day administration of itraconazole oral solution in patients with hematologic malignancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346776

25 May 2018

New investigational antifungal agents for treating invasive fungal infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346776

25 May 2018

Effect of rifampicin on haem and bilirubin metabolism in man.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346776

25 May 2018

[Invasive fungal infections. Epidemiology and new therapies].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346776

15 August 2018

Lipid formulations of amphotericin B: clinical efficacy and toxicities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346776

15 August 2018

1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/16377699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Azoles, a48 llylamines and drug metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/16377699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of fluconazole in normal volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/16377699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.50.1.286-293.2006

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43094166&oldid=1980577646"